ATTR-CM (Transthyretin Amyloid Cardiomyopathy)
3 clinical trials · Condition
◉ Watch ATTR-CM (Transthyretin Amyloid Cardiomyopathy)
| Record | Firm | Date |
|---|---|---|
| Korean Post-marketing Surveillance Vyndamax® Capsules for the Treatment of Transthyretin Amyloid Cardiomyopathy (NCT04801329) | Pfizer | 2021-06-29 |
Track ATTR-CM (Transthyretin Amyloid Cardiomyopathy) automatically
Every clearance here is in the API, with alerts when new ones post.